Abstract
Asthma is a respiratory syndrome occurring in individuals who have genetic susceptibility to develop exaggerated airway narrowing to environmental triggers. The symptoms are generally paroxysmal and typically reversible by the use of drugs relaxing airway smooth muscle (ASM). Despite considerable heterogeneity with respect to etiology, age of onset and severity, all affected individuals display some degree of airway hyperresponsiveness (AHR) upon inhalational challenge with spasmogens. ASM is undoubtedly the motor driving airway responsiveness, but whether defects in its contractile properties underlie AHR is still a matter of debate. Many non-muscle changes in asthmatic airways could contribute to AHR. However, this review focuses on the potential contributions of ASM to AHR. Several of the contractile properties of ASM are discussed, including its force-generating capacity, ability to shorten, degree of stiffness, velocity of shortening and ability to relax. The rationale for any of these individual contractile properties being involved in AHR is first explained followed by a brief summary of the current literature concerning their potential contribution to AHR in asthma.
Keywords: Adaptation, breathing, force, relaxation, shortening, stiffness, velocity, signaling, Asthma, respiratory syndrome, airway smooth muscle
Current Respiratory Medicine Reviews
Title: Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?
Volume: 7 Issue: 4
Author(s): Ynuk Bosse and Peter D. Pare
Affiliation:
Keywords: Adaptation, breathing, force, relaxation, shortening, stiffness, velocity, signaling, Asthma, respiratory syndrome, airway smooth muscle
Abstract: Asthma is a respiratory syndrome occurring in individuals who have genetic susceptibility to develop exaggerated airway narrowing to environmental triggers. The symptoms are generally paroxysmal and typically reversible by the use of drugs relaxing airway smooth muscle (ASM). Despite considerable heterogeneity with respect to etiology, age of onset and severity, all affected individuals display some degree of airway hyperresponsiveness (AHR) upon inhalational challenge with spasmogens. ASM is undoubtedly the motor driving airway responsiveness, but whether defects in its contractile properties underlie AHR is still a matter of debate. Many non-muscle changes in asthmatic airways could contribute to AHR. However, this review focuses on the potential contributions of ASM to AHR. Several of the contractile properties of ASM are discussed, including its force-generating capacity, ability to shorten, degree of stiffness, velocity of shortening and ability to relax. The rationale for any of these individual contractile properties being involved in AHR is first explained followed by a brief summary of the current literature concerning their potential contribution to AHR in asthma.
Export Options
About this article
Cite this article as:
Bosse Ynuk and D. Pare Peter, Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?, Current Respiratory Medicine Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339811798281278
DOI https://dx.doi.org/10.2174/157339811798281278 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments
Current Signal Transduction Therapy Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews Editorial [Hot Topic: New Insight in Obesity and Insulin Resistance (Guest Editor: Geltrude Mingrone)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Basement Membrane Zone in Asthma: The Supracellular Anchoring Network
Current Respiratory Medicine Reviews Interleukin-4-Induced Oxidative Stress Via Microglial NADPH Oxidase Contributes to the Death of Hippocampal Neurons In Vivo
Current Aging Science Overview of the Metallometabolomic Methodology for Metal-Based Drug Metabolism
Current Drug Metabolism Treatment of Viral Encephalitis
Central Nervous System Agents in Medicinal Chemistry The IL-17 Family of Cytokines - Applications in Respiratory Medicine and Allergology
Recent Patents on Inflammation & Allergy Drug Discovery Tachykinins as Therapeutic Targets in Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets Current Perspectives on Cytokines for Anti-retroviral Therapy in AIDS Related B-cell Lymphomas
Current Drug Targets - Infectious Disorders Vaccine Safety Monitoring Systems in Developing Countries: An Example of the Vietnam Model
Current Drug Safety Recent Applications of Triazolopyrimidine-Based Bioactive Compounds in Medicinal and Agrochemical Chemistry
Mini-Reviews in Medicinal Chemistry Prostanoid Receptors as Possible Targets for Anti-Allergic Drugs: Recent Advances in Prostanoids on Allergy and Immunology
Current Drug Targets Characterization, ACE Inhibitory and Antioxidative Properties of Peptide Fractions Obtained from White Shrimp (<i>Litopenaeus vannamei</i>)
Current Bioactive Compounds The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications
Current Pharmaceutical Design Recent Patents on Metalloproteinases as Biomarkers in Osteoarthritis Diagnosis and Treatment
Recent Patents on Biomarkers Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Therapeutic Potential of Nitrate Esters of Commonly Used Drugs
Current Topics in Medicinal Chemistry Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries
Central Nervous System Agents in Medicinal Chemistry